Get started
Author

Natalia López‐González del Rey

Observed names: López González del Rey, Natalia, N. López-González del Rey, N.L. Del Rey, Natalia L. Del Rey, Natalia Lopez Gonzalez del Rey, Natalia Lopez-Gonzalez del Rey, Natalia Lopez‐Gonzalez del Rey, Natalia López González del Rey, Natalia López-González Del Rey, Natalia López-González del Rey
Institutions: Northwestern University, Instituto Cajal, HM Hospitales, University Hospital HM Puerta del Sur, Fundación de Investigación HM Hospitales, Universidad Autónoma de Madrid
Observed institutions: Northwestern University, Universidad San Pablo CEU, Instituto Cajal, Instituto de Salud Carlos III, Biomedical Research Networking Center on Neurodegenerative Diseases, Centro de Investigación Biomédica en Red, HM Hospitales, University Hospital HM Puerta del Sur, Ministerio de Ciencia, Innovación y Universidades, Aligning Science Across Parkinson's, Fundación de Investigación HM Hospitales, Universidad Autónoma de Madrid
ORCID: 0000-0002-1546-1825
Observed ORCID: 0000-0002-1546-1825
OpenAlex ID: A5010398014
Compensatory mechanisms in Parkinson's disease: Circuits adaptations and role in disease modification
2017 · Javier Blesa, Inés Trigo-Damas, et al. · Experimental Neurology · 278
Advances in Parkinson’s Disease: 200 Years Later
2018 · Natalia López-González Del Rey, Ana Quiroga-Varela, et al. · Frontiers in Neuroanatomy · 155
PDF
BBB opening with focused ultrasound in nonhuman primates and Parkinson’s disease patients: Targeted AAV vector delivery and PET imaging
2023 · Javier Blesa, José A. Pineda-Pardo, et al. · Science Advances · 116
PDF
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody
2021 · Guillermo Valenzuela Nieto, Ronald Jara, et al. · Scientific Reports · 52
PDF
The use of nonhuman primate models to understand processes in Parkinson’s disease
2017 · Javier Blesa, Inés Trigo-Damas, et al. · Journal of Neural Transmission · 37
Calbindin and Girk2/Aldh1a1 define resilient vs vulnerable dopaminergic neurons in a primate Parkinson’s disease model
2024 · Natalia López-González del Rey, Nagore Hernández-Pinedo, et al. · npj Parkinson s Disease · 31
Cytology, architecture, development, and connections of the primate striatum: Hints for human pathology
2022 · Natalia López-González del Rey, Miguel Ángel García-Cabezas · Neurobiology of Disease · 31
PDF
Novel models for Parkinson’s disease and their impact on future drug discovery
2018 · Ines Trigo-Damas, Natalia Lopez-Gonzalez del Rey, et al. · Expert Opinion on Drug Discovery · 31
Nigrostriatal iron accumulation in the progression of Parkinson’s disease
2025 · M. López-Aguirre, T. Balzano, et al. · npj Parkinson s Disease · 26
PDF
Animal Models of Parkinson’s Disease
2016 · Javier Blesa, Ines Trigo-Damas, et al. · InTech eBooks · 24
PDF
Neurovascular and immune factors of vulnerability of substantia nigra dopaminergic neurons in non-human primates
2024 · Tiziano Balzano, Natalia López-González del Rey, et al. · npj Parkinson s Disease · 21
Neuron types in the primate striatum: Stereological analysis of projection neurons and interneurons in control and parkinsonian monkeys
2022 · Natalia López‐González del Rey, Inés Trigo‐Damas, et al. · Neuropathology and Applied Neurobiology · 21
PDF
Serotonergic innervation of the striatum in a nonhuman primate model of Parkinson's disease
2019 · Lorena Jiménez-Sánchez, Javier Blesa, et al. · Neuropharmacology · 19
PDF
Molecular targets for endogenous glial cell line-derived neurotrophic factor modulation in striatal parvalbumin interneurons
2020 · Daniel Enterría-Morales, Natalia López-González del Rey, et al. · Brain Communications · 18
PDF
Cerebral metabolic pattern associated with progressive parkinsonism in non-human primates reveals early cortical hypometabolism
2022 · Francisco Molinet-Dronda, Javier Blesa, et al. · Neurobiology of Disease · 16
PDF
Early Paradoxical Increase of Dopamine: A Neurochemical Study of Olfactory Bulb in Asymptomatic and Symptomatic MPTP Treated Monkeys
2017 · Christian Pifl, Harald Reither, et al. · Frontiers in Neuroanatomy · 11
PDF
Recruitment of specific dopamine neuron sub-circuits by opioids
2025 · Sage L. Morison, Luan B. Doster, et al. · Addiction Neuroscience · 8
Lack of Parkinsonian Pathology and Neurodegeneration in Mice After Long-Term Injections of a Proteasome Inhibitor in Olfactory Bulb and Amygdala
2021 · Natalia Lopez-Gonzalez del Rey, Tiziano Balzano, et al. · Frontiers in Aging Neuroscience · 5
Specific proteolysis mediated by a p97-directed proteolysis-targeting chimera (p97-PROTAC)
2025 · Constanza Salinas-Rebolledo, Javier Blesa, et al. · eLife · 3
Parkinson’s Disease-Associated Mutations Affect Mitochondrial Function
2016 · Javier Blesa, Ines Trigo-Damas, et al. · Springer eBooks · 2
Determinants of selective neuronal vulnerability in Parkinson's disease
2021 · N. López-González del Rey, J. Blesa, et al. · ANALES RANM · 1
PDF
Spread of COVID-19 and Its Main Modes of Transmission
2021 · Soraia El Baz, Ahmed Draoui, et al. · Advances in medical diagnosis, treatment, and care (AMDTC) book series · 1
P arkinson's disease: O h my gut!
2017 · Natalia López‐González del Rey, Javier Blesa · Movement Disorders · 1
Author response: Specific proteolysis mediated by a p97-directed proteolysis-targeting chimera (p97-PROTAC)
2025 · Constanza Salinas-Rebolledo, Javier Blesa, et al. · eLife
Author Reply to Peer Reviews of Specific proteolysis mediated by a p97-directed proteolysis-targeting chimera (PROTAC)
2024 · Constanza Salinas-Rebolledo, Javier Blesa, et al.
Works count: 35
Citation count: 908
H-index: 15
I10-index: 16
Year
Topic
Type